[HTML][HTML] The prognostic significance of baseline neutrophil-to-Lymphocyte ratio in melanoma patients receiving immunotherapy

Y Li, Y Meng, H Sun, L Ye, F Zeng… - Journal of …, 2022 - journals.lww.com
Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy.

Y Li, Y Meng, H Sun, L Ye, F Zeng, X Chen… - Journal of …, 2022 - europepmc.org
Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …

[HTML][HTML] The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy

Y Li, Y Meng, H Sun, L Ye, F Zeng… - Journal of …, 2022 - ncbi.nlm.nih.gov
Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy

Y Li, Y Meng, H Sun, L Ye, F Zeng… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy

Y Li, Y Meng, H Sun, L Ye, F Zeng, X Chen… - Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: p> Immunotherapy has revolutionized the treatment in metastatic melanoma, but
alternative biomarkers that are economical, simple and reliable still need to be clarified. In …

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy

Y Li, Y Meng, H Sun, L Ye, F Zeng… - Journal of …, 2022 - ingentaconnect.com
Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …